September 29th, 2009
Podcast 58: A repeat of the July 31 interview with the CDC’s Denise Jamieson on treating pregnant women who have suspected 2009 H1N1.
Pregnant women are at greater risk for flu complications. This week, we repeat a conversation with a CDC researcher who’d just published a paper in Lancet urging prompt treatment with antivirals, even in the face of pending lab results. Contact us at 1-617-440-4374. This week’s links: In Pregnancy, Treat Suspected H1N1 Promptly Without Awaiting Test […]
September 21st, 2009
Podcast 57: Treating community-acquired pneumonia according to the guidelines
When treated according to 2007 IDSA/ATS guidelines, community-acquired pneumonia is a less dangerous disease. You need to administer only 10 guideline-compliant treatments to elderly people, according to one estimate, in order to save a life. A good deal, no? We have the authors of two papers on the benefits of compliance as our guests this […]
September 12th, 2009
Podcast 56: A conversation with two JAMA staffers on their research into “ghost” authorship and “honorary” authorship in the principal medical journals.
We’ve seen research into this area before — 18 months ago, in fact. (We interviewed Joseph Ross back then in Podcast #2.) This time we interview Joseph Wislar, a survey-research specialist at JAMA, and Annette Flanagin, its managing deputy editor. They’ve just presented the abstracted results of a survey on ghost and honorary authorship that […]
September 4th, 2009
Podcast 55: A conversation with Prof. Gilles Montalescot about his JAMA paper on immediate versus delayed intervention in non-ST-segment elevation acute coronary syndrome
French researchers find that in non-ST-elevation acute coronary syndrome, delaying intervention until the next day does not affect the occurrence of death, MI, or the need for urgent revascularization by the one-month mark. We caught up with the study’s first author in Paris. If you want access to earlier podcasts, you’ve come to the right […]
About the Podcast
Comments, suggestions, and story ideas welcome. Learn more about Clinical Conversations.
Follow us:
